Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma
LPAR6 is the most recently determined G-protein-coupled receptor of the lysophosphatidic acid receptor, and very few of studies have demonstrated the performance of LPAR6 in cancers. Moreover, the relationship of LPAR6 to the potential of prognosis and tumor infiltration immune cells in different ty...
Guardado en:
Autores principales: | Jian He, Rui Gao, Mei Meng, Miao Yu, Chengrong Liu, Jingquan Li, Yizhi Song, Hui Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fc06d96d8d3e47ae9e4c9e9316b94409 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
por: Guojun Lu, et al.
Publicado: (2021) -
Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
por: Zhang Zhihui, et al.
Publicado: (2021) -
LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
por: Lin Z, et al.
Publicado: (2021) -
LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
por: Xin Jin, et al.
Publicado: (2021) -
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
por: Maja Šutić, et al.
Publicado: (2021)